http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2011507925-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-36 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J53-007 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-34 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-26 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J53-001 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J21-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-42 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J41-0016 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J21-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P5-36 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-58 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P15-18 |
| filingDate | 2008-12-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2011-03-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2011507925-A |
| titleOfInvention | 17- (1'-propenyl) -17-3'-oxidoestra-4-en-3-one derivatives, uses thereof and pharmaceuticals containing said derivatives |
| abstract | The present invention is represented by the general formula I, wherein the residues Z, R 4 , R 6a , R 6b , R 7 , R 15 , R 16a , R 16b and R 18 have the meaning of claim 1. 17- (1′-propenyl) -17-3′-oxide estra-4-en-3-one derivatives, and solvates, hydrates and salts thereof, and all stereoisomers of these compounds About. The present invention further relates to the application of the medicament for oral contraception and for the treatment of pre-menopausal, pre-menopausal and post-menopausal medical conditions, as well as pharmaceuticals comprising said derivatives, in particular in the indications mentioned above. For the use of these derivatives for. The derivatives according to the invention have a progesterone action and, if preferred, an anti-mineralocorticoid action and a neutral to weak androgenic action. |
| priorityDate | 2007-12-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 206.